Wesfarmers Earnings Calls
| Release date | Feb 18, 2026 |
| EPS estimate | - |
| EPS actual | $0.460 |
| Revenue estimate | - |
| Revenue actual | 15.815B |
| Release date | Oct 31, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
| Release date | Aug 26, 2025 |
| EPS estimate | - |
| EPS actual | $0.420 |
| Revenue estimate | - |
| Revenue actual | 14.463B |
| Release date | Aug 26, 2025 |
| EPS estimate | - |
| EPS actual | - |
| Revenue estimate | - |
| Revenue actual | - |
Last 4 Quarters for Wesfarmers
Below you can see how WFAFY performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Aug 26, 2025 |
| Price on release | $29.79 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Aug 20, 2025 | $29.70 |
| Aug 21, 2025 | $30.25 |
| Aug 22, 2025 | $30.97 |
| Aug 25, 2025 | $29.86 |
| Aug 26, 2025 | $29.79 |
| Aug 27, 2025 | $29.85 |
| Aug 28, 2025 | $30.55 |
| Aug 29, 2025 | $30.00 |
| Sep 02, 2025 | $28.94 |
| 4 days before | 0.303% |
| 4 days after | -2.85% |
| On release day | 0.201% |
| Change in period | -2.56% |
| Release date | Aug 26, 2025 |
| Price on release | $29.79 |
| EPS estimate | - |
| EPS actual | $0.420 |
| Date | Price |
|---|---|
| Aug 20, 2025 | $29.70 |
| Aug 21, 2025 | $30.25 |
| Aug 22, 2025 | $30.97 |
| Aug 25, 2025 | $29.86 |
| Aug 26, 2025 | $29.79 |
| Aug 27, 2025 | $29.85 |
| Aug 28, 2025 | $30.55 |
| Aug 29, 2025 | $30.00 |
| Sep 02, 2025 | $28.94 |
| 4 days before | 0.303% |
| 4 days after | -2.85% |
| On release day | 0.201% |
| Change in period | -2.56% |
| Release date | Oct 31, 2025 |
| Price on release | $27.51 |
| EPS estimate | - |
| EPS actual | - |
| Date | Price |
|---|---|
| Oct 27, 2025 | $29.89 |
| Oct 28, 2025 | $30.97 |
| Oct 29, 2025 | $30.30 |
| Oct 30, 2025 | $28.46 |
| Oct 31, 2025 | $27.51 |
| Nov 03, 2025 | $27.36 |
| Nov 04, 2025 | $27.02 |
| Nov 05, 2025 | $27.16 |
| Nov 06, 2025 | $26.34 |
| 4 days before | -7.96% |
| 4 days after | -4.25% |
| On release day | -0.545% |
| Change in period | -11.88% |
| Release date | Feb 18, 2026 |
| Price on release | $31.61 |
| EPS estimate | - |
| EPS actual | $0.460 |
| Date | Price |
|---|---|
| Feb 11, 2026 | $31.32 |
| Feb 12, 2026 | $30.95 |
| Feb 13, 2026 | $31.25 |
| Feb 17, 2026 | $31.78 |
| Feb 18, 2026 | $31.61 |
| Feb 19, 2026 | $29.47 |
| Feb 20, 2026 | $29.81 |
| Feb 23, 2026 | $29.19 |
| Feb 24, 2026 | $29.04 |
| 4 days before | 0.93% |
| 4 days after | -8.13% |
| On release day | -6.77% |
| Change in period | -7.28% |
Wesfarmers Earnings Call Transcript Summary of Q4 2025
Wesfarmers reported a solid FY2025 result despite challenging trading conditions, with net profit after tax up 14.4% (3.8% excluding significant items). Retail divisions drove performance: Bunnings delivered 3.3% sales growth and +4% EBIT (before property contributions), Kmart Group delivered ~9% earnings growth and strong digital engagement, and Officeworks posted modest sales and earnings growth. WesCEF earnings fell, weighed by lower commodity prices and a $59m contribution loss from the lithium business during refinery ramp-up, although first product was achieved at the Kwinana lithium hydroxide refinery. The Board proposed a capital management distribution of $1.50/share (expected to comprise a $1.10 capital return and $0.40 fully franked special dividend) taking total shareholder distributions for the year to $3.56/share, subject to ATO ruling and shareholder approval. Free cash flow increased to $3.4bn, net CapEx guidance for FY2026 is $1.0–1.3bn (excluding potential sale-and-leaseback proceeds), and the balance sheet remains strong with debt/EBITDA ~1.7x (1.6x after Coregas proceeds) and ~$1.7bn available bank facilities. Key portfolio actions included the sale of Coregas, wind-down and capability transfers from Catch, BPI property structure wind-up and partial sale-and-leaseback activity, and small bolt-on acquisitions. Sustainability and safety metrics improved (injury frequency and scope 1/2 emissions reductions), and management emphasized continued investment in omnichannel, productivity, and new growth platforms (Health, retail media, Anko Global). Lithium (Covalent) will be in a ramp-up/transitional phase over the next ~18 months, and management highlighted ongoing emphasis on capital discipline and shareholder returns.
Sign In
Buy WFAFY